ESSA PHARMA INC's ticker is and the CUSIP is 29668H104. A total of 10 filers reported holding ESSA PHARMA INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $242,000 | -87.1% | 442,000 | -27.0% | 0.07% | -84.7% |
| Q1 2017 | $1,876,000 | +41.1% | 605,300 | 0.0% | 0.44% | -10.1% |
| Q4 2016 | $1,330,000 | -20.7% | 605,300 | +3.2% | 0.50% | -21.4% |
| Q3 2016 | $1,678,000 | -4.3% | 586,700 | +2.9% | 0.63% | -25.3% |
| Q2 2016 | $1,754,000 | +15.1% | 570,232 | +22.0% | 0.84% | -1.1% |
| Q1 2016 | $1,524,000 | +3.0% | 467,333 | +44.9% | 0.85% | +20.5% |
| Q4 2015 | $1,479,000 | -17.7% | 322,500 | +11.8% | 0.71% | -32.0% |
| Q3 2015 | $1,797,000 | – | 288,400 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 1,084,848 | $4,122,000 | 3.04% |